What is HEMLIBRA?
You call the shots
HEMLIBRA gives you the freedom to change your routine and your dosing schedule
HEMLIBRA is the first subcutaneous injection for hemophilia A with or without inhibitors
HEMLIBRA is a medicine that is given as a shot that goes directly under the skin (a subcutaneous injection), so you don't need to find a vein to take your dose of HEMLIBRA.
"HEMLIBRA is better for me and for Carlos because it’s an injection and because of the frequency of the injections after the initial treatment."
— Maria, mom of a teenager with hemophilia A without factor VIII inhibitors, Texas
Learn more about this family's journey with hemophilia
Connect With a Genentech ACM
HEMLIBRA Account and Community Managers (ACMs) can provide support in both English and Spanish.
Chat Easily With Your Doctor
Use this handy discussion guide to get the most out of your conversation.
Consistency you can count on
With the half-life of about 4 weeks, HEMLIBRA is available in your body for weeks, giving you consistent and sustained drug levels*
The term “half-life” in medicine means how long it takes for half the amount of a drug to leave the body. A longer half-life means the medicine stays in your body longer.
The half-life of HEMLIBRA is 646 hours, or about 4 weeks.
The half-life of factor VIII treatment is less than or equal to 48 hours.
†Mean values depicted. Values may vary in individual patients.
Average level of HEMLIBRA in your blood*
Lower levels of HEMLIBRA in blood were predicted in children less than 6 months old.
*For all 3 dosing groups, the levels of HEMLIBRA were within the therapeutic range. A therapeutic range is the range of drug levels that may be expected to achieve a therapeutic treatment effect.
“Regardless of which regimen, all of the levels…are in the therapeutic range and fairly flat and even.”
— Guy Young, MD, Keck School of Medicine of the University of Southern California
While taking HEMLIBRA, it’s not necessary to monitor
your drug levels
HEMLIBRA can be taken once a week, once every 2 weeks, or once every 4 weeks
For the first 4 weeks of treatment, you’ll use HEMLIBRA once a week. This will build up the levels of HEMLIBRA in your blood. After that, your doctor will help you choose a dosing schedule that’s right for you.
For more information on your HEMLIBRA dosing schedules, click here.
“You could literally go from infusing yourself to injecting yourself just twice a month.”
— Gabe, 36-year-old man with hemophilia A without factor VIII inhibitors, Texas
Watch Gabe’s Story
Gabe takes HEMLIBRA every 2 weeks, after having completed the 4 once weekly loading doses.
Please see HEMLIBRA Instructions for Use for full dosing and administration information.
Individual results may vary. Not all patients in the clinical trials had zero bleeds. See results for clinical trial patients with or without factor VIII inhibitors here.
When starting HEMLIBRA, a “loading dose” is taken once weekly for 4 weeks. After that, HEMLIBRA offers 3 regular dosing options: once weekly, once every 2 weeks, or once every 4 weeks. Talk to a doctor about dosing.